Biogen Up Over 10%, Best Performer in the S&P 500 and Nasdaq 100 So Far Today — Data Talk

view original post

Biogen Inc. (BIIB) is currently at $260.17, up $24.18 or 10.25%

 

— Would be highest close since Nov. 16, 2021, when it closed at $261.55

— On pace for largest percent increase since June 7, 2021, when it rose 38.34%

— Currently up three of the past four days

— Currently up two consecutive days; up 11.09% over this period

— Best two day stretch since the two days ending June 8, 2021, when it rose 38.17%

— Up 10.36% month-to-date; on pace for best month since June 2021, when it rose 29.46%

— Up 6.25% year-to-date; on pace for best year since 2017, when it rose 21.96%

— Down 40.66% from its all-time closing high of $438.43 on March 20, 2015

— Up 6.81% from 52 weeks ago (Dec. 30, 2020), when it closed at $243.58

— Down 37.26% from its 52 week closing high of $414.71 on June 10, 2021

— Up 16.19% from its 52 week closing low of $223.92 on Dec. 3, 2021

— Traded as high as $265.54; highest intraday level since Nov. 16, 2021, when it hit $268.72

— Up 12.52% at today’s intraday high; largest intraday percent increase since June 7, 2021, when it rose as much as 63.75%

— Best performer in the S&P 500 today

— Best performer in the Nasdaq 100 today

 

All data as of 3:40:22 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

December 29, 2021 16:00 ET (21:00 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.